Renalytix plc Equity Securities, FV-NI, Realized Gain (Loss)
Renalytix plc (RNLXY) reported Equity Securities, FV-NI, Realized Gain (Loss) of -$42.00 thousand for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-19.
Financial Statements › Income Statement › Other Income
us-gaap:EquitySecuritiesFvNiRealizedGainLoss · last filed 2024-11-19
- Renalytix plc equity securities, fv-ni, realized gain (loss) for the quarter ending 2024-09-30 was -$42.00K.
- Renalytix plc equity securities, fv-ni, realized gain (loss) for the quarter ending 2024-06-30 was -$41.00K.
- Renalytix plc equity securities, fv-ni, realized gain (loss) for the quarter ending 2023-09-30 was $0.00.
- Renalytix plc equity securities, fv-ni, realized gain (loss) for the quarter ending 2023-06-30 was $0.00.
- Renalytix plc equity securities, fv-ni, realized gain (loss) for fiscal 2024 was -$135.00K.
- Renalytix plc equity securities, fv-ni, realized gain (loss) for fiscal 2023 was $0.00.
| Period end | Equity Securities, FV-NI, Realized Gain (Loss) 3 month | Equity Securities, FV-NI, Realized Gain (Loss) 6 month | Equity Securities, FV-NI, Realized Gain (Loss) 9 month | Equity Securities, FV-NI, Realized Gain (Loss) 12 month |
|---|---|---|---|---|
| 2024-09-30 | -$42.00K 10-Q · filed 2024-11-19 | -$83.00K derived: sum of 2 quarters · filed 2024-11-19 | ||
| 2024-06-30 | -$41.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-30 | -$135.00K 10-K · filed 2024-09-30 | ||
| 2024-03-31 | -$94.00K 10-Q · filed 2024-05-15 | |||
| 2023-09-30 | $0.00 10-Q · filed 2024-11-19 | $0.00 derived: sum of 2 quarters · filed 2024-11-19 | ||
| 2023-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-30 | $0.00 10-K · filed 2024-09-30 | ||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-15 |